NCT05426824 2022-06-22
The Whole-course Management of Pegaspargase in ENKTL
The First Affiliated Hospital with Nanjing Medical University
Phase NA Unknown
Clinical Trials
3 trialsNCT03051542 2017-02-13
Evaluating 18F-FDG PET/CT With Liver SUVmax-based Criteria for Prognosis of Patients With Natural Killer/T-cell Lymphoma
Peking University Cancer Hospital & Institute
Phase NA Unknown
NCT03051555 2017-02-13
18F-FDG PET/CT-based Prognostic Model for Predicting Outcome in Patients With Natural Killer/T-cell Lymphoma
Peking University Cancer Hospital & Institute
Phase NA Unknown